Dyne Therapeutics (NASDAQ:DYN) CEO Sells 5,658 Shares
MarketBeat
Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Free Report) CEO John Cox sold 5,658 shares of the company's stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $18.88, for a total value of $106,823.04. Following the completion of the sale, the chief executive officer owned 357,507 shares of the company's stock, valued at $6,749,732.16. This trade represents a 1.56% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
NASDAQ:DYN